MedPath

Comparing inhaled Dexmedetomidine against inhaled Midazolam to suppress anxiety in children.

Phase 1
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/08/056083
Lead Sponsor
Daryl Phils Joe
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA GRADE 1 AND 2

Elective surgeries under general anaesthesia.

Exclusion Criteria

Emergency surgeries.

Known allergies to dexmedetomidine and/or midazolam.

Significant organ dysfunction.

Cardiac dysrhythmias, Congenital heart disease.

Mentally challenged.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compare parent separation anxiety in paediatric population receiving nebulised dexmedetomidine or nebulised midazolam preoperatively.Timepoint: 30 minutes prior to surgery
Secondary Outcome Measures
NameTimeMethod
To compare emergence reaction in paediatric population receiving nebulised dexmedetomidine or nebulised midazolam preoperatively.Timepoint: immediately after surgery to 30 minutes after surgery;To compare mask acceptance in paediatric population receiving nebulised dexmedetomidine or nebulized midazolam preoperativelyTimepoint: On start of anaesthetic procedures.
© Copyright 2025. All Rights Reserved by MedPath